55 East Monroe Street
Suite 3300
Chicago, Illinois 60603-5792

GlaxoSmithKline agrees to pay $750 million penalty for fraud

November 8, 2010
American Medical News

Attorneys representing the Health and Human Services Dept., states and a whistle-blower announced on Oct. 26 that pharmaceutical manufacturer GlaxoSmithKline will plead guilty to selling faulty drugs to Medicare and Medicaid and pay $750 million in penalties. The agreement is the latest milestone in a federal effort to combat Medicare and Medicaid fraud. To read the complete article click here. 

Attorneys at law

 

resources

False claims act basics

Newsroom

Our successes

Our website uses cookies to improve your experience. By continuing to use this website, you are agreeing to our Cookie Policy.